22/01/2025
Tirzepatide is a drug developed by Eli Lilly and Company to treat type 2 diabetes and obesity! 7], the drug is a combination of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP- 1) Dual agonist of the receptor [9]. Its commercial brands are Mounjaro (type 2 diabetes medication) and Zepbound (weight loss medication). The drug is administered as a subcutaneous injection. for testing and research...
Tirzepatide is a drug developed by Eli Lilly and Company to treat type 2 diabetes and obesity! 7], the drug is a combination of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP- 1) Dual agonist of the receptor [9]. Its commercial brands are Mounjaro (type 2 diabetes me...